Nawaloka Hospitals PlcCSELK: NHL.N0000

Quarterly financial statements for period ended 30.09.2025

· Issued by Nawaloka Hospitals PLC

SINCE

1985

NAWALOKA

HOSPITALS PLC

Financial Statements For the Quarter Ended 30t°September 2025

NAVVALOKA

HOSPITALS



27/10/20252:43P.M

Nawaloka Hospitals PLC

Consolidated Statement of Comprehensive Income For the Six Months Ended 30th September 2025

Group

Company

Unaudited

Unaudited

Quarter ended 30th September

Six Month Ended 30th September

Quarter ended 30th September

Six Month Ended 30th September

30.09.2025

Rs'000

30.09.2024

Rs'000

30.09.2025

Rs'000

30.09.2024

Rs'000

30.09.2025

Rs'000

30.09.2024

Rs'000

30.09.2025

Rs'000

30.09.2024

Rs'000

Revenue

3,536,949

3,081,401

6,496,592

5,731,714

1,865,687

1,480,644

3,343,776

2,854,863

Cost of Services

(1,556,843)

(1,453,433)

(2,926,983)

(2,678,019)

(854,153)

(707,106)

(1,587,746)

(1,406,021)

Gross Profit

1,980,106

1,627,968

3,569,608

3,053,695

1,011,534

773,538

1,756,030

1,448,842

Other Income

39,513

31,959

81,644

63,235

25,838

31,133

52,389

61,064

Staff Costs

(638,748)

(548,659)

(1,140,577)

(1,011,638)

(219,544)

(158,558)

(336,003)

(309,386)

Administrative Expenses

(738,008)

(700,942)

(1,434,679)

(1,256,112)

(379,832)

(281,143)

(668,806)

(542,575)

Other Operating Expenses

(32,186)

(20,613)

(61,033)

(47,312)

(18,934)

(20,694)

(36,779)

(32,350)

Profit from Operations

610,676

389,713

1,014,963

801,868

419,062

344,276

766,831

625,595

Finance Income

9,743

6,442

15,705

12,530

5,400

6,090

10,774

10,989

Finance Cost

(267,752)

(182,476)

(496,440)

(394,013)

(123,690)

(128,730)

(245,647)

(273,357)

Net Finance Cost

(258,010)

(176,034)

(480,735)

(381,483)

(118,290)

(122,640)

(234,872)

(262,368)

Gain on Loan Settlement

5,299

-

660,761

-

5,299

-

5,299

Net Profit/(Loss) before Taxation

357,965

213,679

1,194,990

420,385

306,070

221,636

537,257

363,227

Tax Expenses

(63,725)

9,651

(166,010)

(73,176)

(10,480)

(5,147)

(84,876)

(52,500)

Profit/(Loss) for the period

294,240

223,330

1,028,979

347,209

295,590

216,489

452,381

310,727

Total Comprehensive

294,240

223,330

1,028,979

347,209

295,590

216,489

452,381

310,727

Income/(Expense) for the period

Net Profit/(Loss) Attributable to Equity

294,240

223,330

1,028,979

347,209

295,590

216,489

452,381

310,727

holders of the Company

Earnings/(Loss) Per Share

0.21

0.16

0.73

0.25

0.21

0.15

0.32

0.22

Page 1 NH_Quartely Financial Statement 30.09.2025 V9

Nawaloka Hospitals PLC

Consolidated Statement of Financial Position As at 30th September 2025

Group

Company

Group

Company

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Audited

30.09.2025

Rs'000.

30.09.2024

Rs'000.

30.09.2025

Rs'000.

30.09.2024

Rs'000.

31.03.2025

Rs'000.

31.03.2025

Rs'000.

Assets

Non Current Assets

Property, Plant & Equipment

17,190,678

15,811,976

1,728,933

1,867,471

15,937,600

1,813,039

Right of Use Assets

492,752

200,672

336,946

41,320

434,459

262,462

Investment in Subsidiaries

-

-

945,933

945,933

-

945,933

Investment in Equity - Accounted Investees

582,266

359,880

582,266

359,880

582,265

582,265

Total Non Current Assets

18,265,696

16,372,528

3,594,077

3,214,604

16,954,325

3,603,700

Current Assets

Inventories

519,293

510,950

273,035

271,399

476,276

248,967

Trade and Other Receivables

851,714

1,065,384

733,643

979,917

873,100

741,731

Amounts due from Related Parties

962,876

1,017,850

4,473,107

4,272,823

1,100,664

4,640,562

Current Tax Assets

-

3,859

-

-

-

-

Short Term Investment

338,790

279,603

221,865

202,037

269,337

223,752

Cash and Cash Equivalents

319,666

391,940

255,283

313,712

349,810

266,835

2,992,338

3,269,586

5,956,932

6,039,888

3,069,187

6,121,847

Total Assets

21,258,034

19,642,114

9,551,009

9,254,492

20,023,512

9,725,547

Equity and Liabilities

Capital and Reserves

Stated Capital

1,207,389

1,207,389

1,207,389

1,207,389

1,207,389

1,207,389

Revaluation Reserve

4,821,699

4,539,320

419,846

419,462

4,821,699

419,846

Accumulated Profit/(Loss)

(87,245)

(814,112)

721,545

(19,827)

(1,116,224)

269,164

Total Equity

5,941,843

4,932,596

2,348,780

1,607,024

4,912,863

1,896,399

Liabilities

Non Current Liabilities

Provision for Retiring Gratuities

392,640

338,892

250,819

239,248

372,337

230,534

Deferred Tax Liabilities

3,583,128

3,349,331

252,145

223,687

3,576,898

243,774

Borrowings

7,096,224

1,990,590

3,667,768

1,990,590

1,523,866

1,523,866

Lease Liabilities

280,409

68,924

211,045

-

166,013

121,369

11,352,401

5,747,737

4,381,778

2,453,525

5,639,114

2,119,543

Current Liabilities

Trade Creditors and Other Payables

1,827,268

2,428,131

1,385,353

1,367,946

3,001,965

2,057,649

Dividend Payable

4,593

4,593

4,593

4,593

4,593

4,593

Current Tax Liabilities

274,361

159,852

166,417

27,500

223,631

162,412

Amount due to Related Companies

6,372

313,379

443,431

802,226

146,805

507,898

Borrowings

570,960

4,739,640

128,400

2,156,472

5,155,748

2,407,875

Lease Liabilities

8,564

15,607

2,653

360

48,845

34,229

Bank Overdraft

1,271,672

1,300,578

689,603

834,847

889,948

534,948

3,963,791

8,961,780

2,820,450

5,193,943

9,471,535

5,709,604

Total Liabilities

15,316,192

14,709,517

7,202,228

7,647,468

15,110,648

7,829,147

Total Equity and Liabilities

21,258,034

19,642,114

9,551,009

9,254,492

20,023,512

9,725,547

Net Asset Per Share

4.22

3.50

1.67

1.14

3.49

1.35





It is certified that the Financial Statements have been prepared and presented in compliance with the requirements of the Companies Act, No.07 of 2007.

…………………………………………… …………………………………………… Theja Vimuktha De Silva Sampath Thennakoon


Group Chief Financial Officer Chief Financial Officer


…………………………………………… …………………………………………… Dr.H.K.Jayantha Dharmadasa Prof. Lal.G.Chandrasena Chairman / Chief Executive Officer Director/General Manager 28th October 2025 Colombo 02

Nawaloka Hospitals PLC

Statement of Changes in Equity

For the Period Ended 30th September 2025

Group

Stated

Capital Rs'000

Revaluation

Reserve Rs'000

Retained

Earnings Rs'000

Total

Equity Rs'000

Balance as at 01st April 2024

1,207,389

4,539,320

(1,161,311)

4,585,398

Profit/(Loss) for the period

-

-

347,209

347,209

Balance as at 30th September 2024

1,207,389

4,539,320

(814,102)

4,932,607

Balance as at 01st April 2025

1,207,389

4,821,699

(1,116,224)

4,912,863

Profit/(Loss) for the period

-

-

1,028,979

1,028,979

Balance as at 30th September 2025

1,207,389

4,821,699

(87,245)

5,941,843

Company

Stated

Capital

Rs'000

Revaluation

Reserve

Rs'000

Retained

Earnings

Rs'000

Total

Equity

Rs'000

Balance as at 01st April 2024

1,207,389

419,462

(330,554)

1,296,297

Profit/(Loss) for the period

-

310,727

310,727

Balance as at 30th September 2024

1,207,389

419,462

(19,827)

1,607,024

Balance as at 01st April 2025

1,207,389

419,846

269,164

1,896,399

Profit/(Loss) for the period

-

-

452,381

452,381

Balance as at 30th September 2025

1,207,389

419,846

721,545

2,348,780

Notes form an integral part of these Financial Statements. Figures in brackets indicate deductions.

Nawaloka Hospitals PLC

Statement of Cash Flows

For the Period Ended 30th September 2025

GROUP

COMPANY

Period

Ended 30.09.2025 Rs.000

Period

Ended 30.09.2024 Rs.000

Period

Ended 30.09.2025 Rs.000

Period

Ended 30.09.2024 Rs.000

Cash flows from/(used in) Operating Activities

1,194,990

420,385

537,257

363,227

Profit before Tax

Adjustments for :

Depreciation & Amortization

414,006

408,046

135,236

115,359

Finance Cost

496,813

355,440

245,647

243,285

Gain on Loan Settlement

(660,761)

-

(5,299)

-

Interest Income

10,548

(9,762)

1,887

(8,765)

Amortization of Right of Use Assets

80,591

7,565

41,093

540

Provision for Retiring Gratuity

34,331

37,146

20,322

21,978

Operating Profit Before Working Capital Changes

1,570,517

1,218,820

976,144

735,624

Changes in Working Capital

(Decrease)/Increase in Inventories

(43,017)

(160,394)

(24,068)

(94,582)

Decrease/(Increase) in Debtors, Deposits & Advances

21,387

(395,553)

8,089

(375,109)

Increase/(Decrease) in Related Party Balances

(2,645)

(73,881)

102,987

355,733

Increase/(Decrease) in Creditors & Other Payables

(1,174,697)

(375,181)

(672,296)

(506,712)

(1,198,973)

(1,005,009)

(585,289)

(620,670)

Cash Generated from/(Used in) Operating Activities

371,545

213,811

390,855

114,954

Interest Paid

(55,170)

(209,666)

(17,724)

(209,670)

Gratuity Paid

(14,045)

(28,705)

(37)

(4,536)

Income Tax Paid

(109,033)

(25,000)

(72,500)

(25,000)

Net cash Generated from /(Used in) Operating Activities

193,297

(49,560)

300,595

(124,252)

Cash flows from Investing Activities

(Investment)/Withdrawal in Fixed Deposit

(80,000)

(30,000)

-

-

Purchase of Property, Plant & Equipment

(1,667,086)

(223,736)

(51,130)

(124,650)

Net cash Generated from/ (Used in) Investing Activities

(1,747,086)

(253,736)

(51,130)

(124,650)

Cash flows from Financing Activities

Proceeds from Long Term Borrowings

7,054,367

422,000

3,114,367

422,000

Repayments of Long Term Borrowings

(5,832,907)

(509,609)

(3,461,221)

(492,466)

Repayments Proceeds of Leases

(79,542)

(8,422)

(68,818)

-

Net cash Generated from/ (Used in) Financing Activities

1,141,918

(96,031)

(415,672)

(70,466)

Net Increase/(Decrease) in Cash & Cash equivalents

Cash & Cash equivalents during the period

(411,871)

(399,327)

(166,208)

(319,368)

Cash & Cash equivalents at the beginning of the period

(540,137)

(509,311)

(268,112)

(201,768)

Cash and Cash equivalents at the end of the period

(952,008)

(908,638)

(434,320)

(521,136)

Analysis of Cash and Cash equivalents at the end of the period

Cash at Bank & in Hand

319,666

391,940

255,283

313,712

Bank Overdraft

(1,271,672)

(1,300,578)

(689,603)

(834,847)

(952,008)

(908,638)

(434,320)

(521,136)

Nawaloka Hospitals PLC

Notes to the Interim Financial Statements

  1. Corporate Information
    1. General

      Nawaloka Hospitals PLC ('Company') is a quoted public company with limited liability incorporated in Sri Lanka under the provisions of the Companies Act No. 07 of 2007 and the ordinary shares of the company are listed on the Colombo Stock Exchange.

      The registered office and the principal place of business of the Company is located at No. 23, Deshamanya H.K Dharmadasa Mawatha, Colombo 02.

    2. Date of Authorization for Issue

      The Interim Condensed Financial Statements of the Group and Company for the period ended 30th September 2025 were authorized for issue by the Board of Directors on 28th October 2025.

  2. Basis of Preparation

    Interim Financial Statements of Nawaloka Hospitals PLC and its subsidiaries comprise the Consolidated Statement of Financial Position, and the Statements of Comprehensive Income, Other Comprehensive Income, Changes in Equity and Cashflows together with accounting policies and notes thereon and have been prepared in accordance with the Sri Lanka Accounting Standards LKAS 34 - Interim Financial Reporting and requirements of the Companies Act No. 7 of 2007.

    The Financial Statements of the company and those consolidated with such for the interim period have been prepared on the same basis as the most recent audited financial statements.

  3. Other Information
    1. Expense Recognition

      The financial statements include all expenses that are known and measurable as at the reporting date.

    2. Significant Contingencies

      A legal proceeding has been initiated in the Commercial High Court of Colombo under Case No. 59/2023 CO against the company, seeking the cancellation of 5,049,500 shares of Nawaloka College of Higher Studies (Private) Limited which is an associate of the company.

      On 17th December 2024, the Court issued an order regarding the cancellation of these shares. The Company has taken immediate legal measures by filing a notice of appeal on 31st December 2024, followed by an appeal petition on 31st January 2025. The matter remains under judicial consideration, and the Company is actively pursuing its legal rights.

  4. Event After the Reporting Date

No material events have occurred after the reporting date that require disclosure in the interim condensed financial statements.

5.Performance Highlights

Group

Company

Debt/Equity ratio

1.55

2.00

Quick asset ratio

0.62

2.02

Interest cover

2.32

3.43

Interest Yield ratio

0.03

0.02

  1. Investor Information
    1. Public Shareholding Information

      As at

      30.09.2025

      30.06.2025

      Shares held by public

      482,433,208

      482,433,208

      Number of public shareholders

      7,250

      6,909

      Public Holding Percentage

      34.22%

      34.22%

      Compliant under option 3- Float adjusted market capitalization (LKR Mn)

      4,245

      2,895

    2. Directors' Shareholding Information The aggregate shareholding of the Directors as at

      Name of the Director

      30.09.2025

      30.06.2025

      Mr. H K J Dharmadasa

      462,736,182

      462,736,182

      Miss. A G Dharmadasa

      5,066,686

      5,066,686

      Mr. Victor Rajamanner Ramanan

      3,110,088

      3,110,088

      Mr. A G Dharmadasa

      3,004,026

      3,004,026

      Vidya Jyothi Prof. Lal Chandrasena

      601,198

      601,198

      Deshabandu Tilak De Zoysa

      218,000

      218,000

      Dr. I.M.D.Z. Gunasekera

      32,000

      32,000

      Dr. M.Rajakaruna

      NIL

      NIL

      Mr. T K Bandaranayake

      NIL

      NIL

      Dr. M.T.D. Lakshan

      NIL

      NIL

      Mr.V.T.De Zoysa

      NIL

      NIL

      Dr.D.B.S.C.Bandara

      NIL

      NIL

      Mr.C.P.Wijetilleke

      NIL

      NIL

      Dr.R.M.S.Pushpakumara

      NIL

      NIL

      Prof.P.P.M.Jayaweera

      NIL

      NIL

  2. Number of shares representing the entity's stated capital as at

    As at

    30.09.2025

    30.06.2025

    No. of shares

    1,409,505,596

    1,409,505,596

    As at

    30.09.2025

    30.06.2025

    Net Asset value per share (Rs)

    4.22

    4.51

  3. Share prices during the interim period as at

    30.09.2025

    30.06.2025

    Rs.

    Rs.

    Highest Price

    10.50

    6.60

    Lowest Price

    5.80

    4.80

    Last Traded Price

    8.80

    6.00

  4. Major Shareholdings Twenty Largest Shareholders

No

Share Holders Name

As at 30.09.2025

As at 30.06.2025

No. of Shares

%

No. of Shares

%

1

Mr H.K.J. Dharmadasa

462,736,182

32.83

462,736,182

32.83

2

Nawaloka Construction Company (Private) Limited

441,778,880

31.34

441,778,880

31.34

3

Mr. K.D.D. Perera

391,055,692

27.74

389,676,904

27.65

4

Employees Trust Fund Board

6,778,186

0.48

7,722,374

0.55

5

Miss A.G. Dharmadasa

5,066,686

0.36

5,066,686

0.36

6

Mrs P. Nanayakkara

5,066,666

0.36

5,066,666

0.36

7

Mr. L. Hettiarachchi

4,371,592

0.31

4,355,720

0.31

8

Mr. V.R. Ramanan

3,110,088

0.22

3,110,088

0.22

9

Mr A.G. Dharmadasa

3,004,026

0.21

3,004,026

0.21

10

Nawaloka Developments (Pvt) Ltd

2,814,932

0.20

2,814,932

0.20

11

Mrs C.S. Dharmadasa

2,581,866

0.18

2,581,866

0.18

12

Mr. K.S. Warusavitarana

2,472,197

0.18

2,618,786

0.19

13

Tranz Dominion,L.L.C.

2,000,000

0.14

2,000,000

0.14

14

Seylan Bank Plc/Andaradeniya Estate (Pvt) Ltd

1,947,429

0.14

1,947,429

0.14

15

Mr.M.T.Rjab Khan

1,325,000

0.09

1,036,768

0.07

16

Mr. G.C. Goonetilleke

1,205,000

0.09

1,205,000

0.09

17

Mr.B.A.A.S. Basnayaka

1,100,000

0.08

1,100,000

0.14

18

Ranathunga Motors (Pvt) Ltd

1,000,000

0.07

1,000,000

0.10

19

Mr.B.V. Selvanayagam

998,691

0.07

998,691

0.09

20

Mr.W.A.S.P. De Saram

975,203

0.07

-

0.00

Total

1,341,388,316

95.17

1,339,820,998

95.06

Balance held by other shareholders

68,117,280

4.83

69,684,598

4.94

Total No. of shares

1,409,505,596

100.00

1,409,505,596

100.00

Corporate Information

Name of the Company Secretaries to the Company

Nawaloka Hospitals PLC C G Corporate Consultants (Pvt) Ltd No:45, Visakha Road,

Colombo 04,

Company Registration No. Sri Lanka

PQ 78

Auditors Registered Office BDO Partners

No. 23, Deshamanya H. K. Dharmadasa Mawatha, Chartered Accountants of Charter House

Colombo 02, Sri Lanka. 65/2,Chittampalam A, Gardiner Mawatha Colombo 02.

Telephone

(+94 11) 2544444-56, 2305051-79, 5577111

Telefax Lawyer(s)

(+94 11) 2430393 Sanath Wijewardana

E-mail/Website AAL & NP

nawaloka@slt.lk, https://www.nawaloka.com No. 28 Wilson Street Halftsdrop,Colombo 12.

Legal Form

Quoted Public Company with limited liability incorporated in Bankers

Sri Lanka under the Companies Ordinance 1938 and Commercial Bank PLC

Re-registered under the Companies Act No. 07 of 2007. Hatton National Bank PLC Nations Trust Bank PLC Amana Bank PLC

Bank of Ceylon

Board of Directors Sampath Bank PLC

  1. Dr.H.K. Jayantha Dharmadasa (Chairman and CEO) Seylan Bank PLC

  2. Mr.A.G. Dharmadasa (Deputy Chairman) People's Bank

  3. Vidya Jyothi Prof. Lal G. Chandrasena (Director/General Manager) 4.Deshabandu Tilak De Zoysa

  1. Mr. Tissa Kumara Bandaranayake

  2. Mrs. A.G. Dharmadasa

  3. Dr. I. M. D. Z. Gunasekera Subsidiaries

  4. Mr. Victor Rajamanner Ramanan New Nawaloka Hospitals (Pvt) Ltd.

  5. Dr.M.Rajakaruna New Nawaloka Medical Centre (Pvt) Ltd.

  6. Dr. M.T.D. Lakshan Nawaloka Laboratories (Pvt) Ltd. 11.Mr.V.T.De Zoysa

12.Dr.D.B.S.C.Bandara 13.Mr.C.P.Wijetilleke

14.Dr.R.M.S.Pushpakumara Associate

15.Prof.P.P.P.M.Jayaweera Nawaloka College of Higher Studies (Pvt) Ltd.

Company analysis

Earlier from Nawaloka Hospitals

All Nawaloka Hospitals news releases